AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20441725
Drug: Imaginal exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imaginal exposure therapy in subgroup with acute unscheduled cardiovascular events and high baseline PTSD symptoms
Trial: 14649340
Drug: Non-blinded neuromuscular
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-blinded neuromuscular transmission monitoring with rocuronium infusion at 6 microg kg(‐1) min(‐1)
Trial: 14649340
Drug: Blinded neuromuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blinded neuromuscular transmission monitoring with rocuronium infusion at 6 microg kg(‐1) min(‐1) (fixed rate)
Trial: 11011985
Drug: Morning administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning administration of OROS systems
Trial: 11011985
Drug: Night administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Night administration of OROS systems
Trial: 27939406
Drug: Glutaraldehyde-modified allergen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glutaraldehyde-modified allergen extracts administered via therapeutic vaccine adsorbed onto aluminium hydroxide
Trial: 26146015
Drug: Quetiapine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (25 mg)
Trial: 16572265
Drug: Ondansetron (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (12 mg, oral)
Trial: 8766415
Drug: Enalapril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (10 mg t.i.d.)
Trial: 8766415
Drug: Enalapril plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril plus Aspirin (325 mg/day)
Trial: 8766415
Drug: Enalapril plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril plus Aspirin
Trial: 7893494
Drug: Intermittent oxygenated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent oxygenated cold Fresenius solution antegrade and retrograde (FR)
Trial: 3299089
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg of AZT every four hours for 24 weeks
Trial: 29317123
Drug: Baseline serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline serum high‐sensitivity C‐reactive protein (hsCRP) values <10 mg/L categorized into tertiles
Trial: 8968528
Drug: Deflazacort 3
RxNorm normalized name: deflazacort 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deflazacort 3 mg
Trial: 8968528
Drug: Deflazacort 36
RxNorm normalized name: deflazacort 36 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deflazacort 36 mg
Trial: 12402720
Drug: Clonidine 4
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine 4 micrograms kg‐1 infusion over 20 min, PCA clonidine 20 micrograms and morphine 1 mg bolus
Trial: 12402720
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion and PCA morphine 1 mg bolus
Trial: 1384117
Drug: L-carnitine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine (5 g at hours 0, 12, 24, 36 and 2 x 3 g on days 3 to 7 by intravenous infusion over 2 hours)
Trial: 6535339
Drug: Continue medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continue medication
Trial: 30665671
Drug: Control (Post-operative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Post-operative i.v. morphine via patient‐controlled analgesia without paravertebral blockade)
Trial: 29571953
Drug: Phentolamine Mesylate
RxNorm normalized name: Phentolamine Mesylate
DrugBank: Phentolamine (DB00692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phentolamine Mesylate (0.4 mg)
Trial: 18817993
Drug: Pioglitazone 15
RxNorm normalized name: pioglitazone 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone 15 mg/day for initial 14 days after PCI and subsequent 30 mg/day during 6-month follow-up
Trial: 10433310
Drug: Rapid infusion
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid infusion of 100 mg/kg methotrexate (MTX) over 3 hours
Trial: 10433310
Drug: Regular infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular infusion of 100 mg/kg methotrexate (MTX) over 6 hours
Trial: 2323312
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg oral naltrexone
Trial: 26143022
Drug: treatment-naïve subjects
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: treatment-naïve subjects
Trial: 22889694
Drug: Osmotic-release oral
RxNorm normalized name: nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Osmotic-release oral system methylphenidate (OROS‐MPH)
Trial: 18595749
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of intrathecal baclofen (CITB group)
Trial: 18595749
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment only (Control group)
Trial: 9014620
Drug: Rocuronium 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.6 mg kg-1
Trial: 3632163
Drug: Combination clinical
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination clinical plus telephone intervention
Trial: 27146116
Drug: Text messaging
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Text messaging program combined with nicotine patches and gum, quitline referral, and SmokefreeTXT enrollment (4 weeks duration)
Trial: 24074710
Drug: Fuzhenghuayu capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fuzhenghuayu capsule (1.5 g, 3 times/day) with continued oral NAs (one tablet, 1 time/day) for 48 weeks
Trial: 15629418
Drug: Preparation for
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation for Pain Management Intervention (2 sessions including assessment and feedback based on the PPMP)
Trial: 15629418
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (treatment as usual and attention placebo interview)
Trial: 1993963
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (placebo).
Trial: 27590106
Drug: Topical Dexamethasone
RxNorm normalized name: dexamethasone Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Dexamethasone
Trial: 18790598
Drug: Dexamphetamine 10mg
RxNorm normalized name: Dexamphetamine
DrugBank: Dextroamphetamine (DB01576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamphetamine 10mg twice daily
Trial: 12065457
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate (TU) 1000 mg, four injections every 6 weeks plus daily oral placebo
Trial: 2291877
Drug: CGP 6140
RxNorm normalized name: Leucoflex CGP KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGP 6140 (1200 mg single oral dose) after food intake
Trial: 2291877
Drug: CGP 6140
RxNorm normalized name: Leucoflex CGP KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGP 6140 (1200 mg single oral dose) after an overnight fast
Trial: 27301301
Drug: Ozone treatment
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozone treatment for 60 seconds
Trial: 24854218
Drug: Intensive treatment-as-usual
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive treatment-as-usual (TAU)
Trial: 19279381
Drug: Narrow-band UVB
RxNorm normalized name: Band-Aid Hurt-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narrow-band UVB phototherapy combined with efalizumab (1 mg/kg body weight/week)
Trial: 9629935
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (suppositories or intramuscular injections of analgesics on request)
Trial: 26066765
Drug: Romiplostim treatment
RxNorm normalized name: Romiplostim
DrugBank: Romiplostim (DB05332)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Romiplostim treatment
Trial: 28146402
Drug: Corticosteroid at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid at 4 days after ACL injury, placebo injection of saline at 2 weeks
Trial: 28146402
Drug: Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo group (saline injections at both time intervals)
Trial: 21262998
Drug: Losmapimod 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losmapimod 7.5 mg twice daily for 28 days (n=27)
Trial: 8833409
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment, n = 50)
Trial: 16767907
Drug: Gemcitabine (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (1,000 mg/m2 over 30 minutes intravenously weekly for 7 weeks, followed by 1 week of rest, then weekly for 3 weeks every 4 weeks)
Trial: 16767907
Drug: FLEC (5-fluoruracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FLEC (5-fluoruracil 1,000 mg/m2, leucovorin 100 mg/m2, epirubicin 60 mg/m2, carboplatin 300 mg/m2 infused bolus intra-arterially at three-weekly interval for 3 times)
Trial: 10930202
Drug: Epidural analgesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural analgesia with bupivacaine (15 ml, 0.125%)
Trial: 8105072
Drug: IVIG (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG (400 mg per kilogram every 28 days)
Trial: 28994192
Drug: Narrow-diameter implants
RxNorm normalized name: narrowleaf marshelder pollen extract
DrugBank: Iva angustifolia pollen (DB10968)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narrow-diameter implants (NDIs)
Trial: 28994192
Drug: Regular-diameter implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular-diameter implants (RDIs)
Trial: 11469290
Drug: 1.0 ml
RxNorm normalized name: digoxin 0.25 mg in 1.0 mL INTRAVENOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 ml of Depo‐Medrol (40 mg)
Trial: 11469290
Drug: 1.0 ml
RxNorm normalized name: digoxin 0.25 mg in 1.0 mL INTRAVENOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 ml of sterile saline (control)
Trial: 9351634
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) high dose: 1,540 microg per day
Trial: 1797602
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg simethicone
Trial: 31432695
Drug: Glasdegib in
RxNorm normalized name: Product containing glasdegib in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glasdegib in combination with low-dose cytarabine (LDAC)
Trial: 23749683
Drug: Low-dose cytarabine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose cytarabine (LDAC)
Trial: 29882961
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg microdose of dextromethorphan (DM) administered orally with CYP2D6-dependent drugs
Trial: 29882961
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg microdose of dextromethorphan (DM) administered orally without CYP2D6-dependent drugs
Trial: 25168125
Drug: Oral antidiabetes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antidiabetes agents (OADs)
Trial: 18257904
Drug: Ribavirin treatment
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ribavirin treatment
Trial: 20035387
Drug: Autologous stem
RxNorm normalized name: stem bromelain
DrugBank: Stem bromelain (DB12249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous stem cell transplantation and new drug therapies
Trial: 9165189
Drug: Monthly mode
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly mode (MM) during a 3‐month period
Trial: 3618289
Drug: Amitriptyline (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (mean final dose: 130 mg)
Trial: 18816010
Drug: Individual cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual cognitive-behavioral treatment (CBT)
Trial: 16600235
Drug: Past oral
RxNorm normalized name: Oral Paste
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Past oral contraceptive use
Trial: 7662901
Drug: Metoclopramide (MCP)
DrugBank: Metoclopramide (DB01233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoclopramide (MCP) 10 mg
Trial: 1330398
Drug: Quinapril 20
RxNorm normalized name: quinapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril 20 mg administered at 8 AM
Trial: 1330398
Drug: Quinapril 20
RxNorm normalized name: quinapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril 20 mg administered at 10 PM
Trial: 24717698
Drug: Palonosetron 0.0025
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron 0.0025 mg
Trial: 24717698
Drug: Palonosetron 0.0050
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron 0.0050 mg
Trial: 22450972
Drug: Ceftolozane-tazobactam (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftolozane-tazobactam (single dose)
Trial: 22450972
Drug: Ceftolozane alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftolozane alone (multiple doses)
Trial: 22450972
Drug: Ceftolozane-tazobactam (multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftolozane-tazobactam (multiple doses)
Trial: 18283076
Drug: Warfarin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin treatment arm
Trial: 29556414
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy (CPT)
Trial: 11394733
Drug: Extended-release oxybutynin
RxNorm normalized name: oxybutynin Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release oxybutynin 10 mg
Trial: 16415311
Drug: Tolterodine 2
RxNorm normalized name: tolterodine 2 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine 2 mg
Trial: 11394733
Drug: Immediate-release oxybutynin
RxNorm normalized name: oxybutynin Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release oxybutynin 5 mg
Trial: 9699222
Drug: Capsule A
RxNorm normalized name: capsule administration aid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsule A (5 mg MT)
Trial: 2524992
Drug: Baclofen, 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen, 60 mg/day
Trial: 28277874
Drug: HL301 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HL301 0.6 g/day
Trial: 28277874
Drug: HL301 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HL301 1.2 g/day
Trial: 28277874
Drug: All HL301
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All HL301 treatment groups
Trial: 21680092
Drug: Continuous oral
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous oral contraceptive therapy (COCT)
Trial: 12596107
Drug: Topical testosterone
RxNorm normalized name: testosterone Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical testosterone application (Testoviron, 2 mg/kg/wk for 3 weeks)
Trial: 12596107
Drug: Intramuscular testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular testosterone injection (same preparation, weekly for 3 weeks)
Trial: 10509041
Drug: Epirubicin/paclitaxel combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin/paclitaxel combination plus G‐CSF
Trial: 2071350
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg ciprofloxacin 4 hr before surgery (group I)
Trial: 2071350
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg ciprofloxacin 8 hr before surgery (group II)
Trial: 2071350
Drug: Two 750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two 750 mg doses of oral ciprofloxacin every 12 hr, last dose 12 hr before surgery (group III)
Trial: 21914118
Drug: Interlaminar (IL)
RxNorm normalized name: Ile
DrugBank: Isoleucine (DB00167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interlaminar (IL) epidural steroid injection
Trial: 11073753
Drug: Zinc gluconate
RxNorm normalized name: Zinc Gluconate
DrugBank: Zinc gluconate (DB11248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc gluconate (13.3 mg)
Trial: 11073753
Drug: Zinc acetate
RxNorm normalized name: Zinc Acetate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc acetate (5 or 11.5 mg)
Trial: 8250368
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of cefapirine intravenously every eight hours, four times, starting at induction of anaesthesia
Trial: 18209674
Drug: 20% mannitol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% mannitol solution (n = 10 patients)
Trial: 18209674
Drug: 7.45% hypertonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.45% hypertonic saline solution (HSS) (n = 10 patients)
Trial: 16803420
Drug: Valsartan 80
RxNorm normalized name: valsartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 80 or 160 mg/day
Trial: 16803420
Drug: Valsartan 80
RxNorm normalized name: valsartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 80 mg, 160 mg, or 160 mg plus hydrochlorothiazide
Trial: 14763352
Drug: H2-receptor antagonists
RxNorm normalized name: H2-receptor antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H2-receptor antagonists (H2-RA) at double-dose
Trial: 14763352
Drug: Standard doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard doses of H2-RA
Trial: 10982217
Drug: Antihistamine alone
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihistamine alone (n = 13)
Trial: 10982217
Drug: Antihistamine in
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihistamine in combination with intranasal corticosteroid (n = 13)
Trial: 2877875
Drug: Ketamine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (2 mg kg‐1) and alcuronium, supplemented by N2O‐O2 (Group KA)
Trial: 2877875
Drug: Ketamine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (2 mg kg‐1) and alcuronium, supplemented by N2O‐O2 and 0.5% halothane (Group KAH)
Trial: 25216543
Drug: Standard short
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard short infusion (1g imipenem/1g cilastatin over 30min three times daily)
Trial: 20686499
Drug: Olmesartan (10-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan (10-40 mg) plus amlodipine (5 mg) for 8 weeks
Trial: 20686499
Drug: Olmesartan (up-titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan (up-titrated to 20/5, 40/5 or 40/10 mg) plus amlodipine (5 mg)
Trial: 20686499
Drug: Amlodipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5 mg) monotherapy
Trial: 2563743
Drug: Terfenadine, 60
RxNorm normalized name: Terfenadine, 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine, 60 mg taken twice daily
Trial: 8621847
Drug: Loratadine, 10
RxNorm normalized name: Loratadine, 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine, 10 mg once daily
Trial: 25056227
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate nasal spray (FFNS) 55μg, once daily for two weeks
Trial: 9769027
Drug: Propentofylline (PPF)
RxNorm normalized name: propentofylline
DrugBank: Propentofylline (DB06479)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propentofylline (PPF) 300 mg t.i.d. for 12 weeks
Trial: 2677423
Drug: Various active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various active treatments for non-small-cell lung cancer
Trial: 2677423
Drug: Various active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various active treatments for small-cell lung cancer
Trial: 329743
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of mianserin
Trial: 329743
Drug: mianserin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mianserin + alcohol (0.5 g/kg)
Trial: 9205765
Drug: ebrotidine 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ebrotidine 800 mg
Trial: 7708637
Drug: Intramuscular isoniazid,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular isoniazid, pyrazinamide+rifampicin
Trial: 7708637
Drug: Long-term treatment
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term treatment (12 months and more) with all tuberculostatic agents and surgical intervention
Trial: 3308720
Drug: Ceftazidime (80‐100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime (80‐100 mg/kg/day)
Trial: 3308720
Drug: Netilmicin (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Netilmicin (6 mg/kg/day)